Plasma NGAL: So, it Really Is Just Expensive Creatinine!
J Am Coll Cardiol
.
2016 Sep 27;68(13):1432-1434.
doi: 10.1016/j.jacc.2016.07.730.
Authors
Jeffrey M Testani
1
,
Meredith A Brisco
2
Affiliations
1
Program of Applied Translational Research, Yale University, New Haven, Connecticut. Electronic address: jeffrey.testani@yale.edu.
2
Department of Medicine, Cardiology Division, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
PMID:
27659465
PMCID:
PMC5497471
DOI:
10.1016/j.jacc.2016.07.730
No abstract available
Keywords:
NGAL; cardiorenal syndrome; worsening renal function.
Publication types
Editorial
Comment
MeSH terms
Acute-Phase Proteins
Biomarkers
Creatinine*
Lipocalin-2
Lipocalins*
Substances
Acute-Phase Proteins
Biomarkers
Lipocalin-2
Lipocalins
Creatinine
Grants and funding
K23 HL114868/HL/NHLBI NIH HHS/United States
K23 HL128933/HL/NHLBI NIH HHS/United States